Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma

Our study demonstrated that RFX1 downregulation is a new predictive marker of high recurrence risk and poor prognosis of HCC; It has potential to help guide treatment for postoperative HCC patients, especially for small HCC patients.